Sign in

CIK 0001770787

  • Large accelerated filer

10x Genomics, Inc.

Sign in to watch
Ticker
TXG
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
455614458
Phone
+1 925-401-7300
Business address
6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
  1. 4 Open-market sale Chief Financial Officer sold 1,679 shares at $43.34 ($72,762)
  2. 4 Open-market sale Chief Executive Officer sold 7,480 shares at an average $43.52 ($325,567)
  3. 4 Open-market sale Chief Commercial Officer sold 14,718 shares at $42.09 ($619,494)
  4. 4 Planned sale Chief Executive Officer sold 2,000 shares at $39.52 ($79,041)
  5. 4 Planned sale Chief Executive Officer sold 2,000 shares at an average $39.51 ($79,017)
  6. 4 Planned sale Chief Executive Officer sold 2,000 shares at an average $49.37 ($98,739)
  7. 4 Open-market sale Chief Executive Officer sold 3,757 shares at $45.78 ($172,000)
  8. 4 Open-market sale Chief Financial Officer sold 1,678 shares at $45.78 ($76,821)
  9. 4 Open-market sale Chief Commercial Officer sold 9,699 shares at $45.78 ($444,031)
  10. 4 Open-market sale Hindson Benjamin J. sold 3,449 shares at $45.78 ($157,899)
  11. 4 Planned sale Chief Executive Officer sold 2,000 shares at an average $50.11 ($100,212)
  12. 4 Planned sale Hindson Benjamin J. sold 6,970 shares at an average $62.21 ($433,612)
  13. 4 Planned sale Chief Executive Officer sold 40,000 shares at $60.03 ($2,401,088)
  14. 4 Planned sale Hindson Benjamin J. sold 13,940 shares at $60.03 ($836,834)
  15. 4 Planned sale Chief Executive Officer sold 2,000 shares at an average $58.05 ($116,090)
  16. 4 Grant or award Director acquired 1,865 shares (grant or award)
  17. 4 Grant or award Director acquired 1,865 shares (grant or award)
  18. 4 Grant or award Director acquired 1,865 shares (grant or award)
  19. 4 Grant or award Director acquired 1,865 shares (grant or award)
  20. 4 Grant or award Director acquired 1,865 shares (grant or award)

Page 6 of 21 · 410 filings